Kaohsiung, Taiwan

Wei-Hong Tseng

This inventor holds 1 USPTO granted patent. Top assignee: Scinopharm Taiwan, Ltd.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei-Hong Tseng. Retrieved from https://idiyas.com/inventor/wei-hong-tseng-ei9oatgg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wei-Hong Tseng: Innovator in Asymmetric Synthesis

Introduction

Wei-Hong Tseng is a notable inventor based in Kao-Hsiung, Taiwan. He has made significant contributions to the field of chemistry, particularly in the area of asymmetric synthesis. His work has implications for the pharmaceutical industry, especially in the development of important medications.

Latest Patents

Wei-Hong Tseng holds a patent for the "Asymmetric synthesis of a key intermediate for making benazepril and analogues thereof." This invention provides a method for converting an intermediate compound to the desired S,S diastereomer, which is essential for efficiently producing benazepril and its analogues. This innovation showcases his expertise in synthetic chemistry and its applications in drug development.

Career Highlights

Tseng is currently employed at Scinopharm Taiwan, Ltd., where he continues to advance his research and development efforts. His work at Scinopharm has allowed him to collaborate with other experts in the field and contribute to the company's mission of providing high-quality pharmaceutical products.

Collaborations

One of his notable coworkers is George Schloemer. Their collaboration has likely fostered an environment of innovation and creativity, leading to advancements in their respective projects.

Conclusion

Wei-Hong Tseng is a distinguished inventor whose work in asymmetric synthesis has the potential to impact the pharmaceutical industry significantly. His contributions, particularly in the synthesis of benazepril, highlight the importance of innovation in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…